CC0000: Color is not claimed as a feature of the mark.
D10000: "RHPTH[1-84]" AND "FOR INJECTION"
DM0000: The mark consists of a design comprised of four slightly-overlapping geometric shapes together forming a roughly astroidal shape, to the right of which is the word "NATPARA", with the characters and words "(rhPTH [I-84]) FOR INJECTION" appearing below the word "NATPARA".
GS0051: Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, hypoparathyroidism, diseases involving calcium regulation, diseases involving varying levels of calcium in cells and outside cells, endocrine disorders, or bone metabolism disorders containing rhPTH(1-84)
Case File Event Statements
7/3/2017 - 7 years ago
59 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDType:MAB6
7/3/2017 - 7 years ago
58 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
10/4/2016 - 8 years ago
57 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
10/3/2016 - 8 years ago
56 - EXTENSION 5 GRANTEDType:EX5G
9/21/2016 - 8 years ago
55 - EXTENSION 5 FILEDType:EXT5
9/21/2016 - 8 years ago
54 - TEAS EXTENSION RECEIVEDType:EEXT
8/10/2016 - 8 years ago
53 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN